ZOCCALI, CARMINE
 Distribuzione geografica
Continente #
NA - Nord America 1.008
AS - Asia 995
EU - Europa 246
SA - Sud America 3
AF - Africa 2
Totale 2.254
Nazione #
US - Stati Uniti d'America 1.001
SG - Singapore 930
IT - Italia 145
FI - Finlandia 36
NL - Olanda 23
CN - Cina 21
KR - Corea 18
DE - Germania 16
FR - Francia 5
SA - Arabia Saudita 5
IE - Irlanda 4
IN - India 4
CA - Canada 3
HK - Hong Kong 3
JP - Giappone 3
KG - Kirghizistan 3
AL - Albania 2
AT - Austria 2
ID - Indonesia 2
MA - Marocco 2
PL - Polonia 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BR - Brasile 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
GB - Regno Unito 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MX - Messico 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TM - Turkmenistan 1
UA - Ucraina 1
Totale 2.254
Città #
Santa Clara 752
Singapore 603
Helsinki 36
Seoul 18
Ashburn 11
Phoenix 9
Catania 8
Los Angeles 8
Milan 8
Amsterdam 6
Naples 5
Riyadh 5
Dublin 4
Rome 4
Bishkek 3
Brixen 3
Guangzhou 3
Hong Kong 3
Tokyo 3
Bari 2
Bologna 2
Falkenstein 2
Florence 2
Newark 2
Tirana 2
Trieste 2
Turin 2
Valledolmo 2
Vienna 2
West Jordan 2
Ashgabat 1
Bergen 1
Bratislava 1
Brussels 1
Burnaby 1
Cochrane 1
Dallas 1
Douglas 1
Dubai 1
Gioia Tauro 1
Islamabad 1
Kingston 1
London 1
Mascalucia 1
Olímpia 1
Ottawa 1
Pisa 1
Quito 1
Reggio Calabria 1
Reston 1
San José 1
Stockholm 1
Taormina 1
Tel Aviv 1
Vientiane 1
Warsaw 1
Zagreb 1
Totale 1.541
Nome #
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 33
I test diagnostici e l'analisi della curva ROC. 30
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients 21
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 21
Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension 19
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 18
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study 17
Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study 17
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis 17
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 17
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 17
Can the assessment of ultrasound lung water in haemodialysis patients be simplified? 17
Sleep-Disordered Breathing and 24-Hour Ambulatory Blood Pressure Monitoring in Renal Transplant Patients: Longitudinal Study 16
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 16
Be careful with ecological associations 15
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 15
Long-Term Changes in Sleep Disordered Breathing in Renal Transplant Patients: Relevance of the BMI 15
Serum gamma-glutamyltransferase, oxidized LDL and mortality in the elderly 14
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 14
Conducting correlation analysis: important limitations and pitfalls 14
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients 14
FGF23 and the PTH response to paricalcitol in chronic kidney disease 14
Effectiveness of cold HD for the prevention of HD hypotension and mortality in the general HD population 14
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 14
The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney disease 14
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 13
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 13
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 12
Socioeconomic Status and Clinical Outcomes in Chronic Kidney Disease: Bootstrap Validation of a Simple Indicator 12
Intention to treat and per protocol analysis in clinical trials 12
Prognostic values of left ventricular mass index in chronic kidney disease patients 12
Le misure di frequenza negli studi epidemiologici: l incidenza e la prevalenza. 11
An introduction to joint models—applications in nephrology 11
Hypertriglyceridemia modifies the risk by abdominal obesity for all cause and cardiovascular mortality in end stage renal diseases patients. 11
CAN THE ASSESSMENT OF ULTRASOUND LUNG WATER IN HEMODIALYSIS PATIENTS BE SIMPLIFIED? 11
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 11
Lo studio Clinidea BP (Clinical Decisions Guided by Audit in Dialysis). II: utilità della bioimpedance analysis (BIA) per il raggiungimento del target. 11
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 11
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 11
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 11
[Diagnostic tests and ROC curves analysis]. | I test diagnostici e l'analisi della curva ROC. 11
Insulin resistance in chronic kidney disease: a systematic review 11
Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study 10
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 10
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 10
When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice 10
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. 10
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 10
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study 10
Lung ultrasound to detect and monitor pulmonary congestion in patients with acute kidney injury in nephrology wards: a pilot study 9
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 9
Renal safety of catheter-based renal denervation: systematic review and meta-analysis 9
Points of attention when conducting etiological research 9
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 9
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 9
The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease. 8
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial 8
Abdominal obesity modifies the risk of hypertriglyceridemia for a all-cause and cardiovascular mortality in hemodialysis patients 8
C-Reactive Protein and Interleukin-6 modify the risk of high levels of Asymmetric Dimethyl-Arginine (ADMA) for death and cardiovascular events in end stage renal diseases patients. 8
Infiammazione sistemica ed espressione genica nel tessuto adiposo sottocutaneo delle citochine infiammatorie nei pazienti con insufficienza renale cronica. 8
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 8
Role of Obesity and Metabolic Alterations in Hypertensive Renal Disease and in Chronic Kidney Disease 8
Waist circumference modifies the relationship of adipose tissue cytochines leptin and adiponectin with all-cause and cardiovascular mortality in end stage renal disease (ESRD). 8
A comparative study of the risk profile of hemodialysis patients in a for profit network and in two regional registries of the Italian Society of Nephrology 8
Cardiac natriuretic peptides reflect left atrial volume (LAV) and capture longitudinal changes in LAV in ESRD patients. 8
Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease 7
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 7
Nocturnal Hypertension and Altered Night-Day BP Profile and Atherosclerosis in Renal Transplant Patients 7
Fisiologia e patofisiologia del metabolismo calcio-fosforo.Pocket book in Nefrologia. Insufficienza renale cronica e complicanze parenchimali e cardiovascolari. 7
Prognostic value of the New York Heart Association classification in end-stage renal disease. 7
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 7
Systemic and adipose tissue inflammation in chronic kidney disease (CKD) patients. 7
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial 7
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 7
Does asymmetric dimethylarginine play a role in depression in chronic kidney disease patients? 7
Il polimorfismo T585C del gene del recettore Y2 del Neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel predire l'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 7
Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling. 7
Mediadores de inflamacion, disfuncion endotelial y lesiones cardiovasculares en la ERC. 7
[Cox regression analysis in epidemiological research].|La regressione di Cox. 7
La regressione logistica nella ricerca clinica. 7
Systemic and adipose tissue inflammation in chronic kidney disease patients. 7
Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study. 7
Insufficienza renale, ipertensione arteriosa e fattori di rischio cardiovascolare. L'ipertensione arteriosa. Il contributo della ricerca italiana edizione 2007. 7
Vitamin D Receptor (VDR) gene polymorphism is associated with Left Ventricular (LV) mass and predicts Left Ventricular Hypertrophy (LVH) progression in End-Stage Renal Disease (ESRD) patients 7
ENPP1 Gene Polymorphisms are associated with left ventricular (LV) mass and systolic function in end stage renal disease (ESRD) patients. 7
Intact FGF23 and ?-klotho during acute inflammation/sepsis in CKD patients 7
Semeiotica della pressione arteriosa 7
Waist circumference but not Body Mass Index (BMI) reflects the inflammation in dialysis patients. 6
Major adipose tissue Cytokines Leptin and Adiponectin interact with central obesity in explaining the variability in all-cause and cardiovascular death in a high risk population. 6
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies 6
Adiponectin and Leptin in chronic kidney disease: causal factors or mere risk markers? 6
Sleep Disordered Breathing in Renal Transplant Patients. 6
Left atrial volume in end-stage renal disease: a prospective cohort study 6
Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review 6
Salt intake and inflammation in essential hypertension. 6
Obesity, disease progression and Ramipril renoprotective effects in proteinuric chronic nephropathy: a post-hoc analyses of the REIN Study. 6
Cardiomyopathy in chronic kidney disease in end-stage renal disease. Cardiorenal Syndrome. 6
Il rischio cardio-renale delle alterazioni del metabolismo calcio-fosforo e delle calcificazioni cardiovascolari: ipotesi, trial ed evidenze. Pocket book in Nefrologia. Insufficienza renale cronica e complicanze parenchimali e cardiovascolari. 6
Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study 6
CREDIT (Calabria Registry of Dialysis and Transplantation) Working Group. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease 6
Totale 1.064
Categoria #
all - tutte 17.609
article - articoli 9.604
book - libri 24
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 296
Totale 27.533


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202495 0 0 0 0 0 0 0 0 47 9 37 2
2024/20252.369 40 48 577 419 816 45 100 198 124 2 0 0
Totale 2.464